Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bryostatin-1 in Metastatic or Recurrent Head and Neck Cancer
NCT00003443Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jul 1998
- Primary completion
- May 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bryostatin-1 in head and neck squamous cell carcinoma (HNSCC), sponsored by Memorial Sloan Kettering Cancer Center. Started Jul 1998; status: completed.
02
Drugs
bryostatin-1
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00003443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003443.